158 related articles for article (PubMed ID: 30937959)
21. Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study.
Moussa G; Alaaeddine R; Alaeddine LM; Nassra R; Belal ASF; Ismail A; El-Yazbi AF; Abdel-Ghany YS; Hazzaa A
Eur J Med Chem; 2018 Jan; 144():635-650. PubMed ID: 29289887
[TBL] [Abstract][Full Text] [Related]
22. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
Abdelgawad MA; Labib MB; Abdel-Latif M
Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
[TBL] [Abstract][Full Text] [Related]
23. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
[TBL] [Abstract][Full Text] [Related]
24. Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: synthesis, biological evaluation and docking studies.
Aliabadi A; Mohammadi-Farani A; Hosseinzadeh Z; Nadri H; Moradi A; Ahmadi F
Daru; 2015 Jul; 23(1):36. PubMed ID: 26197788
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
[TBL] [Abstract][Full Text] [Related]
26. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
27. Docking, steered molecular dynamics, and QSAR studies as strategies for studying isoflavonoids as 5-, 12-, and 15-lipoxygenase inhibitors.
Cabezas F; Mascayano C
J Biomol Struct Dyn; 2019 Apr; 37(6):1511-1519. PubMed ID: 29624122
[TBL] [Abstract][Full Text] [Related]
28. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
[TBL] [Abstract][Full Text] [Related]
29. Substituted (E)-2-(2-benzylidenehydrazinyl)-4-methylthiazole-5-carboxylates as dual inhibitors of 15-lipoxygenase & carbonic anhydrase II: synthesis, biochemical evaluation and docking studies.
Saeed A; Khan SU; Mahesar PA; Channar PA; Shabir G; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(1):176-181. PubMed ID: 27836541
[TBL] [Abstract][Full Text] [Related]
30. In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation.
Khan H; Zafar M; Den-Haan H; Perez-Sanchez H; Kamal MA
Comb Chem High Throughput Screen; 2018; 21(3):215-221. PubMed ID: 29468959
[TBL] [Abstract][Full Text] [Related]
31. Rational Druggability Investigation Toward Selection of Lead Molecules: Impact of the Commonly Used Spices on Inflammatory Diseases.
Zakerali T; Shahbazi S
Assay Drug Dev Technol; 2018 Oct; 16(7):397-407. PubMed ID: 30106307
[TBL] [Abstract][Full Text] [Related]
32. Dicoumarol derivatives: Green synthesis and molecular modelling studies of their anti-LOX activity.
Simijonović D; Vlachou EE; Petrović ZD; Hadjipavlou-Litina DJ; Litinas ΚE; Stanković N; Mihović N; Mladenović MP
Bioorg Chem; 2018 Oct; 80():741-752. PubMed ID: 30077781
[TBL] [Abstract][Full Text] [Related]
33. Specialized oxygenated heterocyclics from Villorita cyprinoides with cyclooxygenase-2 and 5-lipoxygenase inhibitory properties.
Joy M; Chakraborty K
Food Res Int; 2018 Apr; 106():164-172. PubMed ID: 29579915
[TBL] [Abstract][Full Text] [Related]
34. Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid.
Tsolaki E; Eleftheriou P; Kartsev V; Geronikaki A; Saxena AK
Molecules; 2018 Jul; 23(7):. PubMed ID: 29970872
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
36. Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).
Tian KM; Li JJ; Xu SW
Pharmacol Res; 2019 Mar; 141():541-550. PubMed ID: 30616017
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
[TBL] [Abstract][Full Text] [Related]
38. The importance of 15-lipoxygenase inhibitors in cancer treatment.
Orafaie A; Matin MM; Sadeghian H
Cancer Metastasis Rev; 2018 Sep; 37(2-3):397-408. PubMed ID: 29882120
[TBL] [Abstract][Full Text] [Related]
39. Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancer.
Kakarala KK; Jamil K
J Recept Signal Transduct Res; 2015 Feb; 35(1):26-45. PubMed ID: 25007158
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
